Aurora Cannabis Inc. · TSX:ACB
Aurora Cannabis — Q3 2026 Earnings Presentation
15 slides from Aurora Cannabis's earnings presentation, Feb 4, 2026
Slide 1: Investor Presentation FY26 Q3
INVESTOR PRESENTATION FY26 Q3 February 2026
Slide 2: Disclaimer
Disclaimer CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: Certain information contained in this presentation constitutes goods imported from Canada into the United States, the ability to retain key personnel, the ability to continue investing in infrastructure forward-looking statements under
Slide 3: Key Investment Highlights
Key Investment Highlights ▪ High-growth, high margin Global Medical cannabis focus ▪ Aurora is Canada’s leading exporter of Medical Cannabis with an internal GMP manufacturing capacity and supply network focused on supporting continued global expansion ▪ Sustainable Adjusted Gross Margin1 and Adjust
Slide 4: Q3 FY26 Key Financial Highlights
Q3 FY26 Key Financial Highlights NET REVENUE1 $94MM $6MM 7% “ YoY INCREASE YoY INCREASE ADJ. GROSS MARGIN1 $ $56MM $3MM 6% Aurora has established a commanding leadership position within the rapidly YoY INCREASE YoY INCREASE expanding, high margin, global medical cannabis market. We achieved record q
Slide 5: Q3 FY26 Financial Performance
Q2 FY26 HIGHLIGHTS Q3 FY26 Financial Performance ▪ Total Net Revenue 1 of $94.2M, representing YoY growth of 7% ▪ Record Global Medical Net Revenue 1 of $76.2M, representing YoY growth NET REVENUE & ADJ. GROSS MARGINS1 (millions) of 12% 62% 62% ▪ Record International Net Revenue 1 of 61% 61% 53% 54%
Slide 6: Historical Financial Performance
HISTORICAL HIGHLIGHTS Historical Financial Performance ▪ By focusing on Global Medical Cannabis, we have been able to deliver consistent and profitable growth NET REVENUE1 & ADJUSTED GROSS MARGINS1 (millions) ▪ Net Revenue 1 growth has been 350.0 70% primarily achieved through increases 300.0 59% 60
Slide 7: Balance Sheet Strength
Balance Sheet Strength $154 million $56 million TOTAL CASH UNRESTRICTED CASH Including cash equivalents, restricted cash & short-term investments Strong Working No Cannabis Capital Business Debt 1 Management 1. Aurora's only remaining debt is non-recourse debt of $62 million relating to Bevo Farms L
Slide 8: Aurora has the brand and product portfolio to support Global Medical Cannabis Leadership
Aurora has the brand and product portfolio to support Global Medical Cannabis Leadership FY26 Q3 PERFORMANCE: OUR BRANDS: $94.4MM $18.5MM NET REVENUE1 ADJ. EBITDA1 $15.5MM $154.4M FREE CASH FLOW1 CLOSING CASH BALANCE1 #1 MARKET SHARE CANADIAN MEDICAL LEADING MARKET SHARE IN CANADIAN MEDICAL WITH LEA
Slide 9: Driving Success Globally
KEY HIGHLIGHTS Driving Success Globally ▪ Aurora continues to be a market share leader in the Canadian medical market, supporting consistent, high margin revenue ▪ Aurora maintains leadership positions in Germany, Australia, New Zealand, and the UK INTERNATIONAL & GLOBAL MEDICAL NET REVENUE1 (millio
Slide 10: Leadership in Key Global Cannabis Markets
Leadership in Key Global Cannabis Markets CANADA GERMANY AUSTRALIA UNITED KINGDOM • Leading Medical Market Share as of Q3 FY26 • Continuing to capitalize on descheduling of medical • #2 Market Share as per NostraData • Focused on developing a strong market position • High patient retention creates c
Slide 11: Leading Cannabis Manufacturing Facilities
Leading Cannabis Manufacturing Facilities One of the world’s only fully integrated cannabis producer - combining science-based innovation, GMP certified craft- quality production at scale, and direct distribution in both Canada and Germany ▪ European and Australian (TGA) GMP manufacturing facilities
Slide 12: Leading Science & Innovation Program
Leading Science & Innovation Program ▪ Designed specifically to develop the next big cultivars: high potency, disease A state-of-the-art breeding resistant, with excellent bud structure and density, highly aromatic and expressing and genetics facility, unique terpene profiles sought by patients and
Slide 13: Plant Propagation Business Overview
Plant Propagation Business Overview KEY BUSINESS HIGHLIGHTS Aurora holds a controlling interest in Bevo Farms, an industry leader in plant propagation and one of the largest suppliers of propagated vegetables and ▪ 65-75% of plant propagation revenue normally occurs ornamental plants in North Americ
Slide 14: Aurora is focused on long-term value for shareholders
Aurora is focused on long-term value for shareholders In our view, Aurora is positioned for long-term growth for the following Aurora’s sustained strategic reasons: focus on global medical ▪ We are one of Canada’s largest medical cannabis company cannabis, the highest-margin ▪ We are Canada’s leadin
Slide 15: Investor Presentation
Investor Presentation Email: aurora@icrinc.com Website: auroramj.com/investors